Adverum Biotechnologies

Adverum Biotechnologies is a gene therapy company committed to discovering and developing novel medicines that can offer life-changing therapeutic benefit to patients dealing with chronic or debilitating disease. We are leveraging our next generation adeno-associated virus (AAV)-based directed evolution platform to generate product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein.

Company growth
Type
Public
HQ
Menlo Park, US
Founded
2006
Size (employees)
54 (est)-26%
Adverum Biotechnologies was founded in 2006 and is headquartered in Menlo Park, US

Key People at Adverum Biotechnologies

Linda C. Bain

Linda C. Bain

CFO
Mark S. Blumenkranz

Mark S. Blumenkranz

Founder & Director
Mehdi Gasmi

Mehdi Gasmi

Vice President, Pharmaceutical Development
Steven D. Schwartz

Steven D. Schwartz

Founder & Director
Hans Hull

Hans Hull

Vice President, Legal and Corporate Development
Mitchell H. Finer

Mitchell H. Finer

Founder & Senior Consultant

Adverum Biotechnologies Office Locations

Adverum Biotechnologies has offices in Menlo Park, Philadelphia
Menlo Park, US
Philadelphia, US

Adverum Biotechnologies Metrics

Adverum Biotechnologies Financials

Adverum Biotechnologies's revenue is $572 K in FY, 2014
FY, 2014

Revenue

$572 K

Net Income

$-25.4 M
We estimate that Adverum Biotechnologies's current employees are approximately 45% female and 55% male.

Adverum Biotechnologies Company Life

You may also be interested in